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The method of preparation of highly stable reproducible C60 fullerene aqueous colloid solution is described. The structural 
organization of C6o fullerenes in aqueous solution was studied and analyzed in detail using various techniques such as chemical 
analysis, UV/VIS spectroscopy, atomic force and scanning tunneling microscopy, dynamic light scattering, and zeta potential 
methods.
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Introduction
C60 fullerenes have been intensively investigated in the last 
decades mainly because of the vast range o f their potential 
applications in biomedicine (1, 2). Due to its nanom eter size, 
the pristine C60 fullerenes are able to  interact with biom ole­
cules (3, 4) and penetrate through the cell m em brane (5, 6). 
They exhibit antioxidant properties (7) and, being non-toxic 
(at low concentration at least) (8-13), exert specific health 
effects (e.g., suppress the growth o f m alignant tum ors 
(14, 15)). A lthough these molecules have extremely low water 
solubility (16), they form  stable colloid solutions containing 
individual C60 fullerenes as well as C60 fullerene aggregates 
(clusters) in water (17, 18), when subjected to extended m ix­
ing, sonication, or solvent exchange (19, 20). To understand 
behavior o f C6o fullerene in the biological m edium  (at the lev­
els o f cell, tissue and organ), it is necessary to know exactly 
its concentration in water (dose effect), distribution in size 
and shape (size effect). Because the biomedical effects o f the 
C60 fullerene nanoparticles directly depend on these
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properties (14, 21, 22), their knowledge will enable under­
standing o f “which form  o f C60 fullerene is bioactive, namely 
a single molecule or its cluster?”
The aim  o f this paper is to describe in detail the technology 
of relatively cheap production o f highly stable C60 fullerene 
aqueous colloid solution (C60FAS), comprising the m ethod 
of preparation and detailed analysis (characterization) o f the 
m orphological properties o f the prepared solution. It should 
be noted tha t the m ethod for obtaining aqueous colloid solu­
tion o f C60 fullerene was first proposed by Andrievsky et al. 
(23), however, the procedure outlined in the cited paper was 
not reproducible. W ater soluble C6o fullerene prepared from 
toluene is know n in literature as nano-C60 (9, 10).
Experimental
Method o f  Preparation o f  CM Fullerene Aqueous Colloid 
Solution
C arbon soot was generated by evaporating spectral carbon 
rods (Fa. Schunk) in a d.c. arc at 24 V in a He atmosphere 
(0.2 bar). The soot was extracted for 6 h in boiling toluene. 
Undissolved soot particles were eliminated by filtration. The 
filtrate was then gently w arm ed under flowing nitrogen to 
evaporate the solvent. Preparative separation of C60 and C70 
fullerenes was perform ed through flash chrom atography on 
silica gel/activated carbon with toluene as eluent. The C60 
fullerene fraction had  a purity of >98%. For further
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separation and analysis the fullerene m ixture was dissolved in 
toluene and fractionated with a preparative high-perfor- 
m ance liquid chrom atography (Jasco PU-2086) coupled to  a 
multi-wavelength U V /V IS  detector (Jasco UV-2077) and an 
autosam pler. A preparative Cosmosil Buckyprep Packed 
Colum n with toluene mobile phase was used. The flow rate 
was set to 20 m L /m in . The resultant C60 fullerene fraction 
had a purity o f >99.5%. Further purification was done by 
sublim ation o f the C60 fullerene in a high vacuum  (purity 
99.99% by H PLC  analysis).
For the preparation of C60FAS we used a saturated solu­
tion of pure C6o fullerene (purity > 99.99%>) in toluene with a 
C60 molecule concentration corresponding to m axim um  solu­
bility near 2.9 mg m L -1 , and the same am ount o f distilled 
water in an open beaker. The two phases formed were treated 
in ultrasonic bath. The procedure was continued until the to l­
uene had completely evaporated and the w ater phase became 
yellow colored. F iltration o f the aqueous solution allowed to 
separate the product from  undissolved C60 fullerene. The 
pore size of the filter during the filtration of the aqueous solu­
tion was smaller then 2 fim  (Typ W hatm ann 602 h i /2).
D ifferent concentrations o f C60 fullerene in w ater (from 
0.1 to  0.01 m g m L -1) are obtained by this m ethod. The 
concentration  o f C60 fullerene in the prepared C60FAS 
sample was determ ined as the concentration o f to tal 
organic carbon in aqueous solution and equals to  0.1 mg 
m L -1 (1.39-10-4  M ) (A nalytik Jena TO C  Analyser m ulti 
N /C  3100). The obtained C60FA S is stable for about 12 
m onths at T  — 277 K.
UV/VIS Measurements
U V /V IS  absorption spectrum o f C60 fullerene in water was 
recorded using a double-beam  spectrophotom eter SQ-4802 
(U N ICO , USA). The solution was poured into a polymethy- 
lacrylate cuvette (Spain) having an optical path  length of 
1 cm, which enabled to perform  the m easurem ents in the 
range of 200-700 nm. The tem perature was m aintained con­
stant at T  — 298 K.
AFM  and STM  Measurements
The state o f C60 fullerene was m onitored using atomic force 
m icroscopy (AFM ; ‘‘Solver Pro M ” system; N T -M D T , R us­
sia) and scanning tunneling microscopy (STM; N T -M D T , 
Russia) technique. U nder A FM  and STM study the samples 
were deposited by precipitation from  an aqueous solution 
droplet onto a cleaved m ica substrate (V-l G rade, SPI Sup­
plies) or A u (111) surface (SPI Supplies), respectively. M eas­
urem ents were performed after complete evaporation of the 
solvent. The sample visualization in the A FM  experiments 
was carried out in a semicontact (tapping) m ode using 
N SG 10 (N T-M D T) probes. Typical values o f the tunneling 
current and voltage in the STM  experiments were chosen 
within the ranges of 0.01-0.1 nA and 0.1-0.8 V, respectively.
DLS Measurements
M easurem ent of the size distribution for C60 fullerenes in 
aqueous solution was performed by dynamic light scattering
(DLS) at T  — 298 К  on a Zetasizer Nano-ZS90 (M alvern, 
W orcestershire, U K ). D LS instrum ent equipped with a He- 
N e laser (max 5 mW ) operating at the wavelength o f 633 nm, 
was used.
Zeta Potential Measurements
Zeta potential m easurem ent for C60FAS was carried out on a 
Zetasizer N ano-ZS90 (M alvern, W orcestershire, U K ) at T  — 
298 K. The results were evaluated using the Smoluchowski 
approxim ation, which is known to be rigorously valid only 
for spherical-like particles.
Results and Discussion
Chemical Analysis o f  C60 Fullerene Aqueous Colloid Solution
The purity  o f prepared C60FA S sample (i.e., the presence/ 
absence o f any residual im purities, for exam ple carbon 
black, toluene phase) is an  im portan t factor, which influ­
ences its toxicity (8, 13). The purity  o f prepared C 60FAS 
sample was determ ined by H PLC  and G C /M S  using stan­
dard  program s. Insoluble im purities were determ ined by 
ultra-centrifugation.
Insoluble impurities in the prepared solution were found to 
be less than  1 j i g  m L -1 . Toluene from  the synthesis could not 
be detected in the water by G C /M S  analysis. 1II N M R  spec­
trum  (400 M Hz) of CgoFAS recorded in heavy water did not 
reveal any residual proton signals.
Absorption Spectrum o f  C60 Fullerene Aqueous Colloid 
Solution
To confirm the presence o f C60 fullerene in water, the U V / 
VIS absorption spectrum was recorded (0.1 mg m L -1) in the 
range of the wavelengths A =  200-700 nm  (Figure 1). Three
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Fig. 1. UV/VIS absorption spectrum of C60FAS (0.1 mg mL-1 ).
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intense broad UV absorption bands with m axim a at 208, 265, 
and 347 nm  dom inate which is in good agreement with litera­
ture data  (24).
A I 'M and STM  Characterization o f  C60 Fullerene Aqueous 
Colloid Solution
In  order to  additionally characterize the com position of the 
prepared C60FAS, the state of C60 fullerene was m onitored 
using atomic force microscopy and scanning tunneling 
microscopy technique.
The A FM  picture in Figure 2(a) corresponds to  the con­
centration of C60 fullerene in water equal to  0.1 mg m L -1 . 
Figure 2(b), which corresponds to  ten times less concentra­
tion of C60 fullerene in water (0.01 mg m L -1), dem onstrates 
random ly arranged individual C6o molecules with diameter 
~0 .7  nm  and their bulk sphere-like aggregates with a height 
of 2-50 nm. Figure 3(a) shows the STM image o f surface 
area covered by lone particles and their clusters. Analysis of
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Fig. 3. STM image of C60 fullerenes on gold surface (a) and its 
profile along the marked line (b). C6o fullerenes were precipitated 
from C60FAS with 0.01 mg mL-1 concentration.
the image in the cross-section (Figure 3(b)) indicates that the 
observed objects have the height o f ~0 .7  nm, which corre­
sponds to the size o f lone C60 fullerene. The obtained results 
are in good agreement with theoretical calculations (25) and 
literature data  from  electron microscopy (26, 27).
It is im portan t to  note tha t some individual C6o aggre­
gates w ith a height o f ~100 nm  were also seen in the 
probe m icroscopy images. N um erous experim ental investi­
gations have dem onstrated the polydisperse nature of 
C60FA S, including either m onom ers or aggregates having 
diam eters ranging from  several to  hundreds o f nanom eters 
(26, 28, 29), which fully agrees w ith our A F M /S T M  
results presented above.
DLS Study o f  C60 Fullerene Aqueous Colloid Solution
A typical result o f D LS experiment shown in Figure 4 gives 
the distribution o f light scattering particles according to  their 
hydrodynam ic diameters at a fixed solute concentration 
(0.1 mg m L -1). The m ain fraction of light scattering particles 
had diameters in the range of 100 nm. This result is in a good 
agreement with literature data (30) and the data  o f laser
20
18
16
14
12
£
/л§ 10 
а
0.1 10 100 1000 10000
d. ш
Fig. 2. AFM  images of C60 fullerenes on mica surface, which 
were precipitated from C60FAS with 0.1 (a) and 0.01 (b) mg 
m L-1 concentration.
Fig. 4. Distribution of the scattered light intensity according 
to the diameters of light scattering C60 fullerene particles 
(0.1 mg m L-1 ).
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Fig. 5. Zeta potential of C6oFAS (0.1 mg m L_1).
correlation spectroscopy of pristine C60 fullerene water col­
loid solution, which confirm that the average hydrodynam ic 
radius of nanoparticles is 50 nm  and no further agglom era­
tion is observed (31).
Zeta Potential Study o f  C60 Fullerene Aqueous Colloid 
Solution
The m agnitude of the zeta potential is related to  the stability 
o f colloid dispersions, because it determines the degree and 
nature of the interaction between the particles o f the disperse 
system. The value of zeta potential for C60FAS was equal to 
—23 mV (Figure 5). This result satisfactory agrees with the 
previously published data for colloid C60 fullerenes in water: 
—30 mV (24) and —38 mV (32). A t the same time, Mched- 
lov-Petrossyan et al. reported m uch smaller zeta potential of 
—9 mV (33). A high negative charge of colloid clusters (or, 
m ore strictly, the electrostatic repulsion between the nega­
tively charged clusters) seems to play significant role in the 
stabilization of C60FAS (i.e., it disfavors the aggregation and 
m akes the solution electrically stable).
Conclusions
The m ethod o f p reparation  o f highly stable, purified, and 
reproducible C60 fullerene aqueous colloid solution is 
described. The m orphological properties o f the prepared 
C6oFAS have been investigated by m eans of chemical 
analysis, U V /V IS  spectroscopy, atom ic force and scan­
ning tunneling m icroscopy, dynam ic light scattering, and 
zeta potential m ethods. It was found tha t the properties 
o f the prepared aqueous colloid solution well agree with 
literature data.
The suggested m ethod of preparation is relatively cheap, 
reproducible and allows getting highly concentrated fullerene 
solutions ready for further use in various fields of 
nanobiotechnology.
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